Skip to content

Indochinese periosteal acupuncture method on cognitive function and serum in insomnia inflammatory factors

Indochinese periosteal acupuncture method on cognitive function and serum in insomnia inflammatory factors

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400087775
Enrollment
Unknown
Registered
2024-08-05
Start date
2024-08-12
Completion date
Unknown
Last updated
2024-08-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic insomnia

Interventions

Indo-Periosteal Acupuncture Group:Indo periosteal needling, 1x/day for a total of 10 days. The acupoint Yin Tang (GV28) is located on the forehead, in the central depression at the medial end of the t
Control group:Sleep hygiene education and cognitive therapy in cognitive behavioral therapy for insomnia (CBT-I) were given. At the first session, the therapist gave the patient a copy of the educatio

Sponsors

Shaanxi Provincial Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Meet the DSM-5 diagnostic criteria for insomnia disorder. 2. Age 18-65 years old, including 18 and 65 years old, and gender is not limited. 3. Duration of the disease is consistent with chronic insomnia disorder (duration of the disease = 3 months). 4. 8=Insomnia Severity Index (ISI) =21. 5. Right sharp hand. 6. Signed informed consent.

Exclusion criteria

Exclusion criteria: 1. Insomnia associated with other mental diseases (depression, anxiety, semen, biphasia, etc.), somatic diseases (pain, stroke, coronary heart disease, tumor, etc.). 2. Combined with severe depression, anxiety, or in the course of treatment, severe anxiety and depression, suicidal tendencies. 3. Insomnia caused by poor sleep hygiene. 4. Insomnia caused by jet lag, shift work, etc. 5. People with high risk of sleep apnea (=3 positive items in the Stop Bang questionnaire are considered high risk). 6. People with serious or unstable chronic diseases that are not well controlled, such as high blood pressure, liver and kidney damage, and so on. 7. Alcohol, drug and other substance dependence or abuse. 8. History of central nervous system diseases such as epilepsy, brain tumor, hemangioma, encephalitis, acute brain injury. 9. Pregnant or lactating women, those who plan to become pregnant in the near future. Regular use of any medication that affects the central nervous system or sleep within 2 weeks prior to enrollment, such as sleep aids, antidepressants, and other medications. (e.g., sleep aids, antidepressants, antipsychotics, antiepileptics, etc.). 11. The applicant has received acupuncture, TMS, tDCS, ECT, etc. regularly within 1 month before enrollment. 12. Those with severe visual or hearing impairment who cannot cooperate with the study.

Design outcomes

Primary

MeasureTime frame
Montreal cognitive assessment, MoCA;

Secondary

MeasureTime frame
Cognitive Potentials P300;Insomnia severity index, ISI;TNF-a;IL-6;IL-1ß;

Countries

China

Contacts

Public ContactYuan Jie

Shaanxi Provincial Hospital of Traditional Chinese Medicine

yuanjie8782@163.com+86 152 2924 2772

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026